225 related articles for article (PubMed ID: 31861050)
1. Gigantol Targets Cancer Stem Cells and Destabilizes Tumors via the Suppression of the PI3K/AKT and JAK/STAT Pathways in Ectopic Lung Cancer Xenografts.
Losuwannarak N; Maiuthed A; Kitkumthorn N; Leelahavanichkul A; Roytrakul S; Chanvorachote P
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31861050
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Protein-Protein Interaction Network Identifying c-Met as a Target of Gigantol in the Suppression of Lung Cancer Metastasis.
Aksorn N; Losuwannarak N; Tungsukruthai S; Roytrakul S; Chanvorachote P
Cancer Genomics Proteomics; 2021; 18(3):261-272. PubMed ID: 33893079
[TBL] [Abstract][Full Text] [Related]
3. Gigantol Suppresses Cancer Stem Cell-Like Phenotypes in Lung Cancer Cells.
Bhummaphan N; Chanvorachote P
Evid Based Complement Alternat Med; 2015; 2015():836564. PubMed ID: 26339272
[TBL] [Abstract][Full Text] [Related]
4. Gigantol Inhibits Epithelial to Mesenchymal Process in Human Lung Cancer Cells.
Unahabhokha T; Chanvorachote P; Sritularak B; Kitsongsermthon J; Pongrakhananon V
Evid Based Complement Alternat Med; 2016; 2016():4561674. PubMed ID: 27651818
[TBL] [Abstract][Full Text] [Related]
5. Gigantol inhibits proliferation and enhances DDP-induced apoptosis in breast-cancer cells by downregulating the PI3K/Akt/mTOR signaling pathway.
Huang J; Liu C; Duan S; Lin J; Luo Y; Tao S; Xing S; Zhang X; Du H; Wang H; Huang C; Wei G
Life Sci; 2021 Jun; 274():119354. PubMed ID: 33737087
[TBL] [Abstract][Full Text] [Related]
6. The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells.
Unahabhokha T; Chanvorachote P; Pongrakhananon V
Tumour Biol; 2016 Jul; 37(7):8633-41. PubMed ID: 26733180
[TBL] [Abstract][Full Text] [Related]
7. Gigantol Targets MYC for Ubiquitin-proteasomal Degradation and Suppresses Lung Cancer Cell Growth.
Losuwannarak N; Roytrakul S; Chanvorachote P
Cancer Genomics Proteomics; 2020; 17(6):781-793. PubMed ID: 33099479
[TBL] [Abstract][Full Text] [Related]
8. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
9. Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer.
Cai Y; Hao Y; Xu H; Chen K; Ren B
Exp Ther Med; 2021 Nov; 22(5):1317. PubMed ID: 34630671
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.
Patrad E; Khalighfard S; Amiriani T; Khori V; Alizadeh AM
Cell Oncol (Dordr); 2022 Dec; 45(6):1073-1117. PubMed ID: 36149600
[TBL] [Abstract][Full Text] [Related]
11. Gigantol attenuates the proliferation of human liver cancer HepG2 cells through the PI3K/Akt/NF-κB signaling pathway.
Chen H; Huang Y; Huang J; Lin L; Wei G
Oncol Rep; 2017 Feb; 37(2):865-870. PubMed ID: 27959444
[TBL] [Abstract][Full Text] [Related]
12. Gigantol Attenuates the Metastasis of Human Bladder Cancer Cells, Possibly Through Wnt/EMT Signaling.
Zhao M; Sun Y; Gao Z; Cui H; Chen J; Wang M; Wang Z
Onco Targets Ther; 2020; 13():11337-11346. PubMed ID: 33177841
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of gigantol against hydrogen peroxide‑induced apoptosis in rat bone marrow mesenchymal stem cells through the PI3K/Akt pathway.
Chen H; Huang Y; Huang D; Wu Z; Li Y; Zhou C; Wei G
Mol Med Rep; 2018 Feb; 17(2):3267-3273. PubMed ID: 29257286
[TBL] [Abstract][Full Text] [Related]
14. Gigantol, a promising natural drug for inflammation: a literature review and computational based study.
Chowdhury R; Bhuia S; Rakib AI; Al Hasan S; Shill MC; El-Nashar HAS; El-Shazly M; Islam MT
Nat Prod Res; 2024 Apr; ():1-17. PubMed ID: 38623737
[TBL] [Abstract][Full Text] [Related]
15. Hydroquinone 5-
Hongwiangchan N; Sriratanasak N; Wichadakul D; Aksorn N; Chamni S; Chanvorachote P
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832894
[TBL] [Abstract][Full Text] [Related]
16. Effect of gigantol on the proliferation of hepatocellular carcinoma cells tested by a network-based pharmacological approach and experiments.
Li S; Li H; Yin D; Xue X; Chen X; Li X; Li J; Yi Y
Front Biosci (Landmark Ed); 2022 Jan; 27(1):25. PubMed ID: 35090330
[TBL] [Abstract][Full Text] [Related]
17. Gigantol has Protective Effects against High Glucose-Evoked Nephrotoxicity in Mouse Glomerulus Mesangial Cells by Suppressing ROS/MAPK/NF-κB Signaling Pathways.
Chen MF; Liou SS; Hong TY; Kao ST; Liu IM
Molecules; 2018 Dec; 24(1):. PubMed ID: 30587838
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ mTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells.
Al-Rawashde FA; Al-Wajeeh AS; Vishkaei MN; Saad HKM; Johan MF; Taib WRW; Ismail I; Al-Jamal HAN
Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145344
[TBL] [Abstract][Full Text] [Related]
19. Gene Expression Profiling and Protein Analysis Reveal Suppression of the C-Myc Oncogene and Inhibition JAK/STAT and PI3K/AKT/mTOR Signaling by Thymoquinone in Acute Myeloid Leukemia Cells.
Almajali B; Johan MF; Al-Wajeeh AS; Wan Taib WR; Ismail I; Alhawamdeh M; Al-Tawarah NM; Ibrahim WN; Al-Rawashde FA; Al-Jamal HAN
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337104
[TBL] [Abstract][Full Text] [Related]
20. PI3K/Akt/mTOR signaling pathway in cancer stem cells.
Karami Fath M; Ebrahimi M; Nourbakhsh E; Zia Hazara A; Mirzaei A; Shafieyari S; Salehi A; Hoseinzadeh M; Payandeh Z; Barati G
Pathol Res Pract; 2022 Sep; 237():154010. PubMed ID: 35843034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
